DOCSLIB.ORG

How the Opioid Epidemic Is Affecting Palliative Care Patients

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
How the Opioid Epidemic Is Affecting Palliative Care Patients Copyright By Melissa Gore 2019 How the Opioid Epidemic is Affecting Palliative Care Patients By Melissa Gore A Research Study Presented to the Faculty of the Department of Public Policy and Administration School of Business and Public Administration CALIFORNIA STATE UNIVERSITY BAKERSFIELD In Partial Fulfillment of the Requirements for the Degree of MASTER OF SCIENCE – HEALTH CARE ADMINISTRATION SPRING 2019 H w Lhe Opioid Epidemic i ffecLing Palliali e are Patienl By Meli a Gore Thi the i has b en accepted on behalf f the Department f Publi P Ii y and dmini trati n by their upervi r ommitte : BJ Dat Date OPIOID EPIDEMIC AND PALLIATIVE CARE i Acknowledgements First and foremost, I would like to thank Dr. B.J. Moore for guiding me throughout this program. You have helped me grow and further my education. Without her knowledge and advice, I would not be here. I appreciate both my readers Tony Pallitto and Erika Delmar for assisting me with my thesis. Next, I would like to say thanks to my boss and former coach, Chris Hansen. This opportunity in the HCA program would not have been possible without him. Next, I am very grateful for the friends I have made over the last two years. They have helped motivate me and I have gained some life-long friends. Lastly, I would like to say thanks to my family and boyfriend. They have given continuous support and words of encouragement during my time in this master’s program and I am forever thankful. OPIOID EPIDEMIC AND PALLIATIVE CARE ii Abstract Over the past decade the opioid epidemic has caused many deaths related to drug abuse and addiction in the United States. Palliative and end-of-life care patients rely of various types of opioids to help reduce pain. With new restrictions and regulations, access to prescription opioids has become much harder. The purpose for this study was to explore how the opioid epidemic is affecting palliative and end-of-life care patients. The literature revealed an increase over the last decade of prescription opioids. Multiple factors have aided in the epidemic and since then, regulations and laws have been put in place, making it harder to access prescription opioids. Patients find it difficult receiving proper pain management. Little research has been done on the opioid epidemic and the affect it may have on palliative and end-of-life care patients. Interviews were conducted with eight females from various levels of management in palliative and hospice care organizations. Data was analyzed to develop categories from the participants responses to answer the research question. The categories that were created include: access to prescriptions, alternative medication and treatments, destruction of medications, need for education of MDs, and cultural beliefs. Recommendations were based on the responses from the participants and the literature and included improving the education of physicians and healthcare organizations adoption of evidence-based practices by health care organizations. OPIOID EPIDEMIC AND PALLIATIVE CARE iii Table of Contents Acknowledgements .......................................................................................................................... i Abstract ........................................................................................................................................... ii Chapter One: Introduction .............................................................................................................. 2 Problem Statement ...................................................................................................................... 3 Purpose ........................................................................................................................................ 3 Usefulness ................................................................................................................................... 3 Chapter Two: Literature Review .................................................................................................... 4 Palliative Care ............................................................................................................................. 4 History of Opioids....................................................................................................................... 8 Addiction ................................................................................................................................... 12 Opioid Epidemic ....................................................................................................................... 12 Effect on Palliative care ............................................................................................................ 20 Theory ....................................................................................................................................... 21 Summary ................................................................................................................................... 23 Chapter Three: Methods ............................................................................................................... 24 Research Design ........................................................................................................................ 24 Sample frame ............................................................................................................................ 24 Sample size ............................................................................................................................... 25 Data collection .......................................................................................................................... 25 Data analysis ............................................................................................................................. 25 Methodological rigor ................................................................................................................ 26 IRB approval ............................................................................................................................. 27 Confidentiality .......................................................................................................................... 27 Limitations ................................................................................................................................ 27 Chapter Four: Results ................................................................................................................... 29 Findings .................................................................................................................................... 29 Access to Prescriptions ............................................................................................................. 29 OPIOID EPIDEMIC AND PALLIATIVE CARE iv Alternative Medications and Treatment .................................................................................... 31 Need for Educating Physicians ................................................................................................. 33 Destruction of Medications ....................................................................................................... 33 Cultural Beliefs ......................................................................................................................... 34 Analysis..................................................................................................................................... 36 Theory ....................................................................................................................................... 36 Chapter Five: Summary and Recommendations ........................................................................... 38 Recommendations ..................................................................................................................... 38 Appendix A ................................................................................................................................... 49 Appendix B ................................................................................................................................... 50 Appendix C ................................................................................................................................... 51 Chapter One: Introduction Opioids are prescribed to patients as a standard way to help manage pain. In the early nineties, managing pain was viewed differently than today. In the mid to late 1990’s the “fifth vital sign” was created to help assess a patient with pain that was usually done while Opioids were prescribed until essentially the patient was relieved of their severe pain (Knight, et al. 2017). This might suggest the lack of evidence-based research on the long-term effects of these opioids, or how addicting the drugs are. When patients reported pain from this model, the lack of education on pain management leads to prescribing opioids as an easy and sometimes unnecessary response (Morone &Weiner, 2013). According to the National Association on Drug Abuse (NADA), in 2002 overdoses from opioids, excluding methadone, was just under ten thousand deaths where in 2016 there had been over nineteen thousand deaths per year. Findings from the U.S Department of Health and Human Services data from 2015 indicate on average; ninety Americans die each day (Rudd, Seth, David, & Scholl, 2016). The rise in overdoses is apparent and suggest the
Load more

Recommended publications
  • Design and Synthesis of Functionally Selective Kappa Opioid Receptor Ligands
    Design and Synthesis of Functionally Selective Kappa Opioid Receptor Ligands By Stephanie Nicole Johnson Submitted to the graduate degree program in Medicinal Chemistry and the Graduate Faculty of the University of Kansas in partial fulfillment of the requirements for the degree of Masters in Science. Chairperson: Dr. Thomas E. Prisinzano Dr. Apurba Dutta Dr. Jeffrey P. Krise Date Defended: May 2, 2017 The Thesis Committee for Stephanie Nicole Johnson certifies that this is the approved version of the following thesis: Design and Synthesis of Functionally Selective Kappa Opioid Receptor Ligands Chairperson: Dr. Thomas E. Prisinzano Date approved: May 4, 2017 ii Abstract The ability of ligands to differentially regulate the activity of signaling pathways coupled to a receptor potentially enables researchers to optimize therapeutically relevant efficacies, while minimizing activity at pathways that lead to adverse effects. Recent studies have demonstrated the functional selectivity of kappa opioid receptor (KOR) ligands acting at KOR expressed by rat peripheral pain sensing neurons. In addition, KOR signaling leading to antinociception and dysphoria occur via different pathways. Based on this information, it can be hypothesized that a functionally selective KOR agonist would allow researchers to optimize signaling pathways leading to antinociception while simultaneously minimizing activity towards pathways that result in dysphoria. In this study, our goal was to alter the structure of U50,488 such that efficacy was maintained for signaling pathways important for antinociception (inhibition of cAMP accumulation) and minimized for signaling pathways that reduce antinociception. Thus, several compounds based on the U50,488 scaffold were designed, synthesized, and evaluated at KORs. Selected analogues were further evaluated for inhibition of cAMP accumulation, activation of extracellular signal-regulated kinase (ERK), and inhibition of calcitonin gene- related peptide release (CGRP).
    [Show full text]
  • A Global Review on Short Peptides: Frontiers and Perspectives †
    molecules Review A Global Review on Short Peptides: Frontiers and Perspectives † Vasso Apostolopoulos 1 , Joanna Bojarska 2,* , Tsun-Thai Chai 3 , Sherif Elnagdy 4 , Krzysztof Kaczmarek 5 , John Matsoukas 1,6,7, Roger New 8,9, Keykavous Parang 10 , Octavio Paredes Lopez 11 , Hamideh Parhiz 12, Conrad O. Perera 13, Monica Pickholz 14,15, Milan Remko 16, Michele Saviano 17, Mariusz Skwarczynski 18, Yefeng Tang 19, Wojciech M. Wolf 2,*, Taku Yoshiya 20 , Janusz Zabrocki 5, Piotr Zielenkiewicz 21,22 , Maha AlKhazindar 4 , Vanessa Barriga 1, Konstantinos Kelaidonis 6, Elham Mousavinezhad Sarasia 9 and Istvan Toth 18,23,24 1 Institute for Health and Sport, Victoria University, Melbourne, VIC 3030, Australia; [email protected] (V.A.); [email protected] (J.M.); [email protected] (V.B.) 2 Institute of General and Ecological Chemistry, Faculty of Chemistry, Lodz University of Technology, Zeromskiego˙ 116, 90-924 Lodz, Poland 3 Department of Chemical Science, Faculty of Science, Universiti Tunku Abdul Rahman, Kampar 31900, Malaysia; [email protected] 4 Botany and Microbiology Department, Faculty of Science, Cairo University, Gamaa St., Giza 12613, Egypt; [email protected] (S.E.); [email protected] (M.A.) 5 Institute of Organic Chemistry, Faculty of Chemistry, Lodz University of Technology, Zeromskiego˙ 116, 90-924 Lodz, Poland; [email protected] (K.K.); [email protected] (J.Z.) 6 NewDrug, Patras Science Park, 26500 Patras, Greece; [email protected] 7 Department of Physiology and Pharmacology,
    [Show full text]
  • ESI-MS Method for the Simultaneous Detection of Five Major Opium Alkaloids
    Development and evaluation of an LC- ESI-MS method for the simultaneous detection of five major opium alkaloids M.G. Carlin PhD 2015 Development and evaluation of an LC-ESI- MS method for the simultaneous detection of five major opium alkaloids Michelle Groves Carlin A thesis submitted in partial fulfilment of the requirements of the University of Northumbria at Newcastle for the degree of Doctor of Philosophy Research undertaken in the Department of Applied Sciences, Faculty of Health & Life Sciences August 2015 Abstract The aim of this work was to establish an analytical method for the simultaneous detection of five major opium alkaloids in poppy seeds by liquid chromatography-electrospray ionisation-mass spectrometry (LC- ESI-MS). Once opium alkaloids were detected in poppy seeds, toxicological studies were carried out to establish if these compounds were detected in oral fluid (OF) of participants who ingested muffins containing poppy seeds. It is known that the ingestion of poppy seeds has caused positive opiate drug test results and much work has been reported in the scientific literature in the last 20 years. Researchers in the field have investigated alternatives to differentiate between heroin administration and that of other opiate drugs versus poppy seed ingestion. Most of the work which has been carried out relates to establishing illicit heroin use by examining biological matrices for the presence of acetylcodeine, thebaine, papaverine, noscapine and their associated metabolites. The research methodology consisted of establishing an LC-ESI-MS method for the simultaneous detection of five major opium alkaloids (morphine, codeine, thebaine, papaverine and noscapine). A deuterated internal standard (morphine-d3) was used for the quantitation of alkaloids in harvested poppy seeds and oral fluid samples.
    [Show full text]
  • Un Siècle D'histoire Et D'utilisation Du Sucre De Betterave
    1812-1914 : un siècle d’histoire et d’utilisation du sucre de betterave Matthieu Nomblot To cite this version: Matthieu Nomblot. 1812-1914 : un siècle d’histoire et d’utilisation du sucre de betterave. Sciences pharmaceutiques. 2019. dumas-02434066 HAL Id: dumas-02434066 https://dumas.ccsd.cnrs.fr/dumas-02434066 Submitted on 9 Jan 2020 HAL is a multi-disciplinary open access L’archive ouverte pluridisciplinaire HAL, est archive for the deposit and dissemination of sci- destinée au dépôt et à la diffusion de documents entific research documents, whether they are pub- scientifiques de niveau recherche, publiés ou non, lished or not. The documents may come from émanant des établissements d’enseignement et de teaching and research institutions in France or recherche français ou étrangers, des laboratoires abroad, or from public or private research centers. publics ou privés. U.F.R. Santé Faculté des sciences pharmaceutiques THESE Pour obtenir le diplôme d’état de Docteur en Pharmacie Préparée au sein de l’Université de Caen Normandie 1812-1914 : Un siècle d’histoire et d’utilisation du sucre de betterave Présentée par Matthieu Nomblot Soutenue publiquement le 10 mai 2019 devant le jury composé de Professeur des universités, Faculté des Pr David Garon Président du jury sciences pharmaceutiques, Caen Maître de conférences, Faculté des Dr Jean-Philippe Rioult Directeur de thèse sciences pharmaceutiques, Caen Pharmacien titulaire, Pharmacie Dr Matthieu Perdriel Examinateur d’Hastings, Caen Thèse dirigée par Jean-Philippe Rioult LISTE DES ENSEIGNANTS
    [Show full text]
  • ROBERT JOHN KANE: Química Inorgánica Y Productos Químicos De Planta
    Revista CENIC. Ciencias Biológicas ISSN: 0253-5688 ISSN: 2221-2450 [email protected] Centro Nacional de Investigaciones Científicas Cuba ROBERT JOHN KANE: Química Inorgánica y productos químicos de planta Wisniak, Jaime ROBERT JOHN KANE: Química Inorgánica y productos químicos de planta Revista CENIC. Ciencias Biológicas, vol. 50, núm. 2, 2019 Centro Nacional de Investigaciones Científicas, Cuba Disponible en: https://www.redalyc.org/articulo.oa?id=181263501005 PDF generado a partir de XML-JATS4R por Redalyc Proyecto académico sin fines de lucro, desarrollado bajo la iniciativa de acceso abierto Artículos de revisión ROBERT JOHN KANE: Química Inorgánica y productos químicos de planta ROBERT JOHN KANE: Química Inorgánica y productos químicos de planta Jaime Wisniak [email protected] University of the Negev, Israel Resumen: Robert John Kane (1801-1891), fue un médico y químico inglés al que le debemos un nuevo y eficiente proceso para la síntesis de los cloruros de yodo, el estudio de la naturaleza y comportamiento del amoníaco y sus derivados, y la existencia de compuestos que contienen nitrógeno en la forma de NH2 (amidógeno), que no son amidas y resultaban de la acción del amoníaco sobe la base de un óxido. La acción del Revista CENIC. Ciencias Biológicas, vol. amoníaco sobre el óxido mercúrico resultaba en un amoniuro, un compuesto altamente 50, núm. 2, 2019 fulminante. Kane aisló, identificó y determinó la propiedades de una serie de productos Centro Nacional de Investigaciones derivados de plantas, entre ellos la tebaína, la dumasina (ciclopentanona), el compuesto Científicas, Cuba activo de una variedad de aceites esenciales (romero, mejorana, menta, poleo, menta verde, lavanda y sasafrás), el material colorante de las bayas de Persia, y varios líquenes Recepción: 26 Junio 2019 Aprobación: 26 Agosto 2019 de las especies Rocella y Lecanora.
    [Show full text]
  • Chemiegeschichtliche Daten Organischer Substanzen
    Chemiegeschichtliche Daten organischer Substanzen Rudolf Werner Soukup 2020 Vorwort Nach den „Chemiegeschichtlichen Daten organischer Naturstoffe“ und den „Chemiege- schichtlichen Daten anorganischer Substanzen“ fehlte noch ein derartiges Lexikon für organischen Substanzen. Ein derartiges Unterfangen erschien mir allerding angesichts der Tatsache, dass heute so an die 100 000 000 Kohlenstoffverbindungen bekannt sind, absolut wahnwitzig. Die Ereignisse des Jahres 2020 veranlassten mich dann doch dazu, für einige wenige, speziell ausgewählte Kohlenstoffverbindungen chemiehistorische Daten zu sammeln. Es geht um mehr oder weniger repräsentative Beispiel für die allerwichtigsten Gerüstsubstanzen und einige wenige Vertreter funktioneller Gruppen. Das Ganze ist als „work in progress“ zu verstehen. Es sollte demnach möglich sein, laufend Ergänzungen und Korrekturen vorzunehmen. Überschneidungen mit der Datensammlung „Chemiege- schichtlichen Daten organischer Naturstoffe“ ließen sich nicht ganz vermeiden. Wenn es um Substanzen geht, die eher der Naturstoffchemie zuzuordnen sind, wie Enzyme, Eiweiße, Zucker etc., ist dennoch zu empfehlen, zuerst das Lexikon der organischen Naturstoffe zu befragen und dann erst unter den organischen Substanzen zu recherchieren. Es wurden von bestimmten Stoffklassen (wie z.B. Zucker oder Aminosäuren jeweils zwei bis drei repräsentative Beispiele berücksichtigt. Ähnliches gilt für die Vertreter der unterschiedlichen funktionellen Gruppen. Da es derzeit noch keinen Index gibt, sollte bei der Suche unter speziellen Substanznamen die word-Suchfunktion verwendet werden. Die üblichen Namen findet man in der Spalte 1, veraltete historische Namen sowie der IUPAC-Namen sind in Spalte 2 zu finden. Perchtoldsdorf im Mai 2020 Rudolf Werner Soukup Abkürzungen: >…...…Siehe: Chemiegeschichtliche Daten organischer Substanzen >DA….Siehe: Chemiegeschichtliche Daten anorganischer Substanzen >DN….Siehe: Chemiegeschichtliche Daten organischer Naturstoffe Umseitig: Illustration aus: "Opfindelsernes Bog V" (Book of inventions V) 1880 by André Lütken, Ill.
    [Show full text]
  • Corantes Biológicos Evolução Histórica No Estudo Histocitológico “Os Pioneiros”
    CORANTES BIOLÓGICOS EVOLUÇÃO HISTÓRICA NO ESTUDO HISTOCITOLÓGICO “OS PIONEIROS” Fernando Colonna Rosman Novembro de 2012 2a edição 2018 IN MEMORIAM HENRIQUE LEONEL LENZI (1943-2011) Médico patologista, pesquisador Instituto Oswaldo Cruz, FIOCRUZ Rio de Janeiro, RJ (1984-2011) Jacopo Berengario da Carpi (1460-1530) =1521-1523: Jacopo Berengario da Carpi, médico anatomista italiano, já injetava corantes na luz dos vasos sanguíneos, bem antes de se corarem os tecidos. Foi o primeiro anatomista a valorizar as ilustrações no livro de anatomia, como importante complemento do texto. = Commentaria cum amplissimis additionibus super anatomia Mundini. Ed. Hieronymus de Benedictis (Bologne), 1521. = Isagogae breves perlucidae ac uberrimae in anatomiam humani corporis a communi medicorum academia usitatam, a Carpo, in almo Bononiensi Gymnasio ordinariam chirurgiae docente, ad suorum Oil on canvas by an Emilian painter of 17th Century scholasticorum preces in lucem datae. Ed. Benedetto di Ettore Faelli (Bologne), 1523. Antonius Mizaldus (1510-1578) = Século XVI: Na França já era sabido que as vacas que comem a planta Rubia tinctorum (Rubiaceae) [madder root] ficavam com o leite vermelho, assim como os ossos dos bezerros. =1567: Antonius Mizaldus, astrólogo e médico francês, publicou o primeiro relato sobre a coloração dos tecidos, tendo como base a coloração dos ossos pela rúbia (garança). Garança (Rubia tinctorum) = 1826: Pierre Jean Robiquet (1780-1840), químico francês, do extrato das raízes de Rubia tinctorum (garança, madder root), (Rubiaceae), obteve os corantes vermelhos alizarina e Madder root Robiquet (1780-1840)) purpurina. = 1886: Karl James Peter Graebe (1841-1927) e Karl Theodor Libermann (1842- 1914), químicos alemães, sintetizaram a alizarina a partir do antraceno obtido do Alizarina Red S alcatrão da hulha.
    [Show full text]
  • Conditional Gene Knockout Approach to Investigate Delta Opioid Receptor Functions in the Forebrain Paul Chu Sin Chung
    Conditional gene knockout approach to investigate Delta opioid receptor functions in the forebrain Paul Chu Sin Chung To cite this version: Paul Chu Sin Chung. Conditional gene knockout approach to investigate Delta opioid recep- tor functions in the forebrain. Neurobiology. Université de Strasbourg, 2013. English. NNT : 2013STRAJ054. tel-01124236 HAL Id: tel-01124236 https://tel.archives-ouvertes.fr/tel-01124236 Submitted on 6 Mar 2015 HAL is a multi-disciplinary open access L’archive ouverte pluridisciplinaire HAL, est archive for the deposit and dissemination of sci- destinée au dépôt et à la diffusion de documents entific research documents, whether they are pub- scientifiques de niveau recherche, publiés ou non, lished or not. The documents may come from émanant des établissements d’enseignement et de teaching and research institutions in France or recherche français ou étrangers, des laboratoires abroad, or from public or private research centers. publics ou privés. Thèse de Doctorat de l’Université de Strasbourg En Aspects Moléculaires et Cellulaires de la Biologie Mention Neurosciences Présentée par Paul Chu Sin Chung pour l’obtention du grade de Docteur de l’Université de Strasbourg Conditional gene knockout approach to investigate Delta Opioid Receptor functions in the forebrain Thèse soutenue publiquement le 4 octobre 2013 A l’Institut de Génétique et de Biologie Moléculaire et Cellulaire Membres du Jury : Pr Brigitte L. Kieffer Directeur de thèse, Strasbourg Dr Rafael Maldonado Rapporteur externe, Barcelone Pr Andreas Zimmer Rapporteur externe, Bonn Dr Pierre Veinante Rapporteur interne, Strasbourg Dr Ian Kitchen Membre invité, Guildford « Et il n’est rien de plus beau que l’instant qui précède le voyage, l’instant où l’horizon de demain vient nous rendre visite et nous dire ses promesses » Milan Kundera 2 Remerciements… Ce travail de thèse a été effectué sous la direction du professeur Brigitte Kieffer.
    [Show full text]
  • Pierre-Jean Robiquet
    EMERGENT TOPICS ON CHEMISTRY EDUCATION [GREEN CHEMISTRY] Educ. quím., 24 (núm. extraord. 1), 139-149, 2013. © Universidad Nacional Autónoma de México, ISSN 0187-893-X Publicado en línea el 30 de enero de 2013, ISSNE 1870-8404 Pierre-Jean Robiquet Jaime Wisniak 1 ABSTRACT Pierre-Jean Robiquet (1780-1840), a French pharmacist, made important contributions in the areas of mineral chemistry, mineral and vegetable pigments, and extractive and analytical chemistry. Alone, or with his collaborators he discovered asparagine (with Vauquelin), alizarin and purpurin in madder (with Colin), orcin, and orcein in lichens, glycyrrhizin in licorice, cantharidin in cantharides, amygdaline in bitter almonds (with Boutron-Charlard), caffeine (independently of Pelletier, Caventou, Runge) and narcotine and codeine in opium. KEYWORDS: vegetable dyes, alizarin, purpurin, orcin, glycyrrhizin, cantharidin, amygdalin, alkaloids, caffeine, opium, morphine, codeine Resumen their property confiscated, and their business ruined. Pierre-Jean Robiquet (1780-1840), farmacéutico Francés, Friends of this father took their four children, suddenly left realizó importantes contribuciones en las áreas de química without lodging and resources, into their care. By lack of al- mineral, pigmentos minerales y orgánicos, y química ex- ternative, Robiquet entered as an apprentice to a carpenter, tractiva y analítica. Solo, o con sus colaboradores, descubrió who for a certain payment and conditions, agreed to teach la asparagina (con Vauquelin), la alizarina y la purpurina him the art. To take him out of this painful situation, it was (con Colin), la orcina y la orceína en líquenes, la glicirrizina decided to put him under the tuition of a good relative living en regaliz, la cantaridina en las cantáridas, la amigdalina en in Lorient, and who, after a year, succeeding in getting him las almendras amargas (con Boutron-Charlard), la cafeína an apprenticeship in the pharmacy of Clary (Bussy, 1841).
    [Show full text]
  • 6B. Earth Sciences, Astronomy & Biology
    19-th Century ROMANTIC AGE Astronomy, Biology, Earth sciences Collected and edited by Prof. Zvi Kam, Weizmann Institute, Israel The 19th century, the Romantic era. Why romantic? Borrowed from the arts and music, but influenced also the approach to nature and its studies: emphasizing descriptive biology and classification of animals and plants. ASTRONOMY and EARTH SCIENCES EARTH SCIENCES AGE OF THE UNIVERSE AND OF EARTH How can we measure the age of the universe? The size of the universe? The size and distances of stars? How can we estimate the age of earth? How were the various chemical elements created? Characteristic of the 19th century is the transition from geology of stone collecting and sorting, to attempts on modeling the mechanisms shaping the earth crust. The release from religious constraints provided space for testing new theories based on fossils, distributions of rock and soil types, earthquakes, volcanic eruptions, soil erosion and sediment, glaciers and their traces, sea floors, earth core etc. Before the 19th century, a reminder: 1650 James Ussher, 1581-1656, an Irish archbishop, claim earth was created 4000 BC, before the first day of creation. 1715 Edmond Halley, 1656-1742, Calculated an estimation of earth age from seawater salinity. He assumed the ancient see contained sweet water, and salinity rose due to earth erosion. 1785 Dr. James Parkinson, 1755-1824, a surgeon (who identified what was later called “Parkinson disease”) and a geologist, one of the founders of the geological society and a supporter of “catastrophism”. Saved the nature museum in Leicester square from bankruptcy of his owner, Sir Ashton Lever.
    [Show full text]
  • From Morphine to Endogenous Opioid Peptides, E.G., Endorphins: the Endless Quest for the Citation: A.M
    Firenze University Press www.fupress.com/substantia Research Article From morphine to endogenous opioid peptides, e.g., endorphins: the endless quest for the Citation: A.M. Papini (2018) From morphine to endogenous opioid pep- perfect painkiller tides, e.g., endorphins: the endless quest for the perfect painkiller. Sub- stantia 2(2): 81-91. doi: 10.13128/sub- stantia-63 Anna Maria Papini Copyright: © 2018 A.M. Papini. This is Interdepartmental Laboratory of Peptide and Protein Chemistry and Biology, Department an open access, peer-reviewed article of Chemistry “Ugo Schiff”, University of Florence, Via della Lastruccia 13, I-50019 Sesto published by Firenze University Press Fiorentino (Italy) (http://www.fupress.com/substantia) Email: [email protected] and distribuited under the terms of the Creative Commons Attribution License, which permits unrestricted use, distri- Abstract. Opium was known since the Neolithic era and in 5th century wild Papa- bution, and reproduction in any medi- ver use was reported to induce sleep and relieving pain. First active component iso- um, provided the original author and lated from Opium was morphine, the paradigm of a natural product discovered 150 source are credited. years before isolation of endogenous opioid ligands, brain pentapeptide enkephalins. Data Availability Statement: All rel- Since then many endorphin peptides and their mode of action were discovered. Native evant data are within the paper and its endorphins were characterized thanks to the synthetic antagonist naloxone. Supporting Information files. Keywords. Opium, morphine, peptides, peptidomimetics, analgesics. Competing Interests: The Author(s) declare(s) no conflict of interest. MORPHINE: A PARADIGMATIC EXAMPLE OF A NATURAL PRODUCT MIMICKING ENDOGENOUS MOLECULES The story of morphine (Figure 1) and its analogues is a paradigmatic example of the classical pathway to drug development undertaken by those researchers starting from a natural compound.
    [Show full text]
  • Opium: Explorations of an Ambiguous Drug
    3 Opium: Explorations of an Ambiguous Drug Introduction Since at least the 1960s, when increasing drug abuse became an issue of political and public concern in the West, the history of opium has been of considerable interest. As in other areas of historical investigation inspired by today’s problems, the focus tended to be on precursor stages or roots of present phenomena, i.e., attention was devoted mainly to earlier perceptions of the drug’s psychotropic and addictive properties, and to medical and social responses to this. The by now classical study in this field was published in 1962/63 by Glenn Sonnedecker, who gave an overview of the development of the concept of opiate addiction from the sixteenth to the twentieth century. Sonnedecker documented Western knowledge about the dangers of habitual consumption of the drug since the Renaissance, mainly from reports of travellers to countries of the Near, Middle and Far East about indigenous opium-eaters. Yet he also pointed out that an awareness of opium addiction as a serious medical or even social problem could not be found in the West before the nineteenth century. 1 This was confirmed by John C. Kramer in a brief survey of the medical uses and misuses of opium in Western countries during the seventeenth and eighteenth centuries, and more recently in a comprehensive study of the history of opium addiction by Margit Kreutel. 2 Accordingly most of the scholarly work on historical aspects of opium has been devoted to developments from the late eighteenth or early nineteenth century onwards, when the non-medical, recreational use of the drug became popular in the Western world.
    [Show full text]